Advertisement

Topics

Global Alliance to Eliminate Lymphatic Filariasis Company Profile

01:34 EST 11th December 2018 | BioPortfolio


News Articles [779 Associated News Articles listed on BioPortfolio]

At the10th GAELF meeting, India reiterates its commitment to eliminate lymphatic filariasis by 2020

The 10th meeting of the Global Alliance to Eliminate Lymphatic Filariasis (GAELF) which concluded recently in New Delhi with joint health secretary Vikas Sheel urging all partners to come out of silos...

Study Triggers Change in WHO Treatment Guidelines for Lymphatic Filariasis

NewsResearchers have shown that a single "cocktail" of three pill-based anti-parasite medications is significantly more effective at killing microscopic larval worms in people diagnosed with lymphatic...

CWRU-Led study triggers change in WHO treatment guidelines for lymphatic filariasis

(Case Western Reserve University) Researchers from Case Western Reserve University School of Medicine have shown that a single 'cocktail' of three pill-based anti-parasite medications is significantly...

Mosquito screening useful in monitoring lymphatic filariasis re-emergence

(PLOS) To ensure elimination of the Wuchereria bancrofti, a parasitic roundworm that causes lymphatic filariasis, public health workers must follow up mass drug administration with careful monitoring ...

Wonderful news for global public health! Advancing toward Elimination of Lymphatic Filariasis https://www.nejm.org/doi/full/10.1056/NEJMe1811455 … Kudos to @Merck @GSK who donated 6.7bn rx over past 18yrs, prevented/cured millions cases of this horr

Wonderful news for global public health! Advancing toward Elimination of Lymphatic Filariasis https://www.nejm.org/doi/full/10.1056/NEJMe1811455 … Kudos to @Merck @GSK who donated 6....

Elephantiasis Lymphatic Filariasis Pipeline Review, H2 2018 [Report Updated: 17072018] Prices from USD $2000

Elephantiasis Lymphatic Filariasis Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Elephantiasis Lymphatic Filariasis Pipeline Revi...

Novel gene mutation found in lymphatic disorder

(Children's Hospital of Philadelphia) Pediatric researchers have identified a gene mutation that causes a serious lymphatic condition, and used that knowledge to restore normal lymphatic vessels in mo...

LSTM led partnership receives funding to develop drug for treating two neglected tropical diseases

An LSTM led partnership has been awarded nearly £1.5 million from the Medical Research Council for the pre-clinical development of a candidate drug to treat onchocerciasis and lymphatic filariasis, b...

PubMed Articles [1116 Associated PubMed Articles listed on BioPortfolio]

Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature.

WHO's Global Programme to Eliminate Lymphatic Filariasis (LF) uses mass drug administration (MDA) of anthelmintic medications to interrupt LF transmission in endemic areas. Recently, a single dose com...

Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission.

A global strategy of mass drug administration (MDA) has greatly reduced the burden of lymphatic filariasis (LF) in endemic countries. In Madagascar, the National Programme to eliminate LF has scaled-u...

Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models.

With the 2020 target year for elimination of lymphatic filariasis (LF) approaching, there is an urgent need to assess how long mass drug administration (MDA) programs with annual ivermectin + albendaz...

Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016.

Under the Global Programme to Eliminate Lymphatic Filariasis (LF), American Samoa conducted seven rounds of mass drug administration (MDA) from 2000-2006. The World Health Organization recommends syst...

A Trial of a Triple-Drug Treatment for Lymphatic Filariasis.

The World Health Organization has targeted lymphatic filariasis for global elimination by 2020 with a strategy of mass drug administration. This trial tested whether a single dose of a three-drug regi...

Clinical Trials [1436 Associated Clinical Trials listed on BioPortfolio]

Research for Elimination of Lymphatic Filariasis (ICIDR)

The purpose of this study is to check blood samples for lymphatic filariasis to determine whether the recent Program to Eliminate Lymphatic Filariasis was successful in controlling lymphat...

Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis

The DOLF Triple Drug Therapy for Lymphatic Filariasis study will determine the frequency, type and severity of adverse events following triple-drug therapy (IVM+DEC+ALB, IDA) compared to t...

Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis

This study will assess the impact of 2-drug (DA) or 3-drug (IDA) regimens on lymphatic filariasis infection parameters in communities. Parameters measured will include: circulating filaria...

Research for Elim of Filariasis

Wuchereria bancrofti, is a mosquito-transmitted parasite that causes deforming lymphatic filariasis in the tropics. Improved treatment methods have led to new thinking that it should be po...

Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali

Lymphatic filariasis is a public health problem in Mali. The existing data are not up to date and most of them are more than 15 years old. To address this issue in April 2000, the investig...

Companies [1461 Associated Companies listed on BioPortfolio]

Global Alliance to Eliminate Lymphatic Filariasis

GSK, Merck Sharp & Dohme (MSD), and the MECTIZAN® Donation Program (MDP)

The MECTIZAN® Donation Program (MDP) was established in 1987 to provide medical, technical and administrative oversight of the donation of MECTIZAN® by MSD for the treatment...

Sepsis Alliance

Sepsis Alliance is a nonprofit patient advocacy organization in the U.S. promoting awareness of sepsis. Sepsis Alliance operates by providing information and education to raise aw...

EcoHealth Alliance

Building on 40 years of innovative science, EcoHealth Alliance (formerly Wildlife Trust) is a non-profit international conservation organization dedicated to protecting wildlife and safeguarding human...

Alliance for Case Studies for Global Health

The multi-sector Case Studies for Global Health initiative was conceived by members of the Alliance in December 2007. Representatives from each organization met many times to shape the collective visi...

More Information about "Global Alliance to Eliminate Lymphatic Filariasis" on BioPortfolio

We have published hundreds of Global Alliance to Eliminate Lymphatic Filariasis news stories on BioPortfolio along with dozens of Global Alliance to Eliminate Lymphatic Filariasis Clinical Trials and PubMed Articles about Global Alliance to Eliminate Lymphatic Filariasis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Global Alliance to Eliminate Lymphatic Filariasis Companies in our database. You can also find out about relevant Global Alliance to Eliminate Lymphatic Filariasis Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record